Inal, A. Et Al. 2013. Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).

Inal, A., Koca, D., Kaplan, M. A., Kucukoner, M., Urakci, Z., Dogan, E., ... Isikdogan, A.(2013). Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands

Inal, A. Et Al. "Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013

Inal, A. Et Al. "Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

Inal, A. Et Al. (2013) . "Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={A. Inal Et Al. }, title={Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}